Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
valuation ratios | |
|---|---|
| pe ratio | -12.89 |
| peg ratio | 1.98 |
| price to book ratio | 1.34 |
| price to sales ratio | 3.89 |
| enterprise value multiple | -11.92 |
| price fair value | 1.34 |
profitability ratios | |
|---|---|
| gross profit margin | 54.41% |
| operating profit margin | 12.19% |
| pretax profit margin | -38.96% |
| net profit margin | -30.18% |
| return on assets | -7.34% |
| return on equity | -9.72% |
| return on capital employed | 3.11% |
liquidity ratio | |
|---|---|
| current ratio | 6.14 |
| quick ratio | 4.52 |
| cash ratio | 0.83 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 249.58 |
| operating cycle | 314.93 |
| days of payables outstanding | 37.92 |
| cash conversion cycle | 277.01 |
| receivables turnover | 5.59 |
| payables turnover | 9.63 |
| inventory turnover | 1.46 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.13 |
| debt equity ratio | 0.19 |
| long term debt to capitalization | 0.14 |
| total debt to capitalization | 0.16 |
| interest coverage | 6.41 |
| cash flow to debt ratio | 0.30 |
cash flow ratios | |
|---|---|
| free cash flow per share | 7.98 |
| cash per share | 58.10 |
| operating cash flow per share | 14.72 |
| free cash flow operating cash flow ratio | 0.54 |
| cash flow coverage ratios | 0.30 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | 2.18 |
Frequently Asked Questions
Bio-Rad Laboratories, Inc. (BIO) published its most recent earnings results on 31-10-2024.
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Bio-Rad Laboratories, Inc. (NYSE:BIO)'s trailing twelve months ROE is -9.72%.
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Bio-Rad Laboratories, Inc. (BIO) currently has a ROA of -7.34%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
BIO reported a profit margin of -30.18% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
Apple's current ratio, which measures its ability to pay short-term obligations, was 6.14 in the most recent quarter. The quick ratio stood at 4.52, with a Debt/Eq ratio of 0.19.